semaglutide and parkinson's Can Help in Psychiatry Too? Research Shows Promise for AD PD Glucagon-like peptide-1 class drugs show

For pharma companies, these advancements open new opportunities in formulation development, manufacturing partnerships, and global expansion

J Neurosci 29:1555115563

Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats

Simultaneously, patients should also acquire knowledge about the gastrointestinal adverse reactions that may arise from oral administration and the endocrine system adverse events that may occur from subcutaneous injections

Because of a lack of evidence to determine the best therapy, initial management includes conservative methods such as oral medications, physical therapy, core strengthening, and injection therapy